Concerns regarding design, analysis, and interpretation of the Morrison study on hormonal contraceptive use and acquisition of cervical infections [1] (multiple letters)

Sexually Transmitted Diseases

Volumn 32, Issue 10, 2005, Pages 644-645

  Warner, Pamela ^a   Morrison, Charles S ^b   Wong, Emelita L ^b   Blumenthal, Paul D ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

CHLAMYDIASIS; CONDOM; GONORRHEA; HORMONAL CONTRACEPTION; HUMAN; INFECTION RISK; LETTER; ORAL CONTRACEPTION; RISK FACTOR; UTERINE CERVICITIS;

CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; RESEARCH DESIGN; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL DISEASES;

EID: 26444483302     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000175374.98875.33     Document Type: Letter

References (0)